169 related articles for article (PubMed ID: 37897648)
1. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients.
Zhao YY; Ge HJ; Yang WT; Shao ZM; Hao S
Breast Cancer Res Treat; 2024 Feb; 203(3):543-551. PubMed ID: 37897648
[TBL] [Abstract][Full Text] [Related]
2. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
Li Y; Zhang N; Zhang H; Yang Q
J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ.
Liu Y; Yu T
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11181-11191. PubMed ID: 37354223
[TBL] [Abstract][Full Text] [Related]
4. Secretory carcinoma of the breast: a genetically defined carcinoma entity.
Diallo R; Tognon C; Knezevich SR; Sorensen P; Poremba C
Verh Dtsch Ges Pathol; 2003; 87():193-203. PubMed ID: 16888913
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma.
Li L; Wu N; Li F; Li L; Wei L; Liu J
Cancer Biol Med; 2019 Feb; 16(1):139-146. PubMed ID: 31119054
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and survival outcomes in breast carcinosarcoma: A SEER population-based study.
Lin S; Liu C; Tao Z; Zhang J; Hu X
Breast; 2020 Feb; 49():157-164. PubMed ID: 31812891
[TBL] [Abstract][Full Text] [Related]
7. Secretory Carcinoma of the Breast Mimicking Invasive Ductal Carcinoma: A Case Report.
Kovalenko I; Roy P; Soni B; Sangha L; Toom S
Am J Case Rep; 2022 Aug; 23():e936665. PubMed ID: 35982591
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Characteristics and Prognosis of Squamous Cell Carcinoma of the Breast: A Population-Based Analysis.
Han Y; Wang J; Wang Z; Xu B
Cancer Control; 2021; 28():10732748211044355. PubMed ID: 34654324
[TBL] [Abstract][Full Text] [Related]
9. Genomic landscape of secretory carcinoma of the breast with axillary lymph node metastasis.
Chen M; Pu T; Wei B; Bu H; Tang P; Zhang Z
Pathol Res Pract; 2022 Mar; 231():153790. PubMed ID: 35158121
[TBL] [Abstract][Full Text] [Related]
10. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
[TBL] [Abstract][Full Text] [Related]
11. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.
Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.
Lai HW; Tseng LM; Chang TW; Kuo YL; Hsieh CM; Chen ST; Kuo SJ; Su CC; Chen DR
Breast; 2013 Oct; 22(5):968-73. PubMed ID: 23787124
[TBL] [Abstract][Full Text] [Related]
13. Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China.
Shi WB; Yang LJ; Hu X; Zhou J; Zhang Q; Shao ZM
PLoS One; 2014; 9(6):e101390. PubMed ID: 24977705
[TBL] [Abstract][Full Text] [Related]
14. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features, treatment patterns, and prognosis of squamous cell carcinoma of the breast: an NCDB analysis.
Zhu L; Chen K
BMC Cancer; 2019 Jan; 19(1):26. PubMed ID: 30621628
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
[TBL] [Abstract][Full Text] [Related]
17. Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base.
Jacob JD; Hodge C; Franko J; Pezzi CM; Goldman CD; Klimberg VS
J Surg Oncol; 2016 Jun; 113(7):721-5. PubMed ID: 27040042
[TBL] [Abstract][Full Text] [Related]
18. Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.
Del Castillo M; Chibon F; Arnould L; Croce S; Ribeiro A; Perot G; Hostein I; Geha S; Bozon C; Garnier A; Lae M; Vincent-Salomon A; MacGrogan G
Am J Surg Pathol; 2015 Nov; 39(11):1458-67. PubMed ID: 26291510
[TBL] [Abstract][Full Text] [Related]
19. The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer.
Hu J; Lang R; Zhao W; Jia Y; Tong Z; Shi Y
Breast Cancer Res Treat; 2023 Jul; 200(1):23-36. PubMed ID: 37160814
[TBL] [Abstract][Full Text] [Related]
20. Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature.
Ghilli M; Mariniello MD; Scatena C; Dosa L; Traficante G; Tamburini A; Caporalini C; Buccoliero AM; Facchini F; Colizzi L; Quattrini Li A; Landucci E; Manca G; Naccarato AG; Caramella D; Favre C; Roncella M
Breast Cancer Res Treat; 2018 Aug; 170(3):445-454. PubMed ID: 29616377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
